Suven Life Sciences Limited
15 clinical trials · Sponsor
◉ Watch Suven Life Sciences Limited
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE) (NCT07540364) | Suven Life Sciences Limited | 2026-06-19 |
| Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients (NCT06836063) | Suven Life Sciences Limited | 2025-07-15 |
| Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants (NCT06705088) | Suven Life Sciences Limited | 2025-01-07 |
| Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients (NCT06126497) | Suven Life Sciences Limited | 2024-02-05 |
| Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type (NCT05397639) | Suven Life Sciences Limited | 2022-11-01 |
| A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy (NCT04072380) | Suven Life Sciences Limited | 2019-09-21 |
Track Suven Life Sciences Limited automatically
Every clearance here is in the API, with alerts when new ones post.